In vivo leukocyte changes induced by Escherichia coli subtilase cytotoxin

Infection and Immunity

Volumn 79, Issue 4, 2011, Pages 1671-1679

  Wang, Hui ^a   Paton, Adrienne W ^a   McColl, Shaun R ^a   Paton, James C ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; CYTOTOXIN; GLUCOSE REGULATED PROTEIN 78; SUBTILASE CYTOTOXIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; ESCHERICHIA COLI; HEMOLYTIC UREMIC SYNDROME; INNATE IMMUNITY; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOCYTOSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; CELL SEPARATION; ESCHERICHIA COLI PROTEINS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; LEUKOCYTES; MALE; MICE; MICE, INBRED BALB C; SUBTILISINS;

EID: 79953296658     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01204-10     Document Type: Article

References (27)

1. Bliss, S. K., B. A. Butcher, and E. Y. Denkers. 2000. Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection. J. Immunol. 165:4515-4521.
2. Byres, E., A. W. Paton, J. C. Paton, J. C. Löfling, and D. F. Smith, et al. 2008. Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin. Nature 456:648-652.
3. 5 toxin that targets the ER chaperone BiP. Cell. Microbiol. 10:795-806.
4. Ferens, W. A., and C. J. Hovde. 2000. Antiviral activity of Shiga toxin 1: suppression of bovine leukemia virus-related spontaneous lymphocyte proliferation. Infect. Immun. 68:4462-4469.
5. Fernández, G. C., et al. 2000. Shiga toxin-2 induces neutrophilia and neutrophil activation in a murine model of hemolytic uremic syndrome. Clin. Immunol. 95:227-234.
6. Forsyth, K. D., A. C. Simpson, M. M. Fitzpatrick, T. M. Barratt, and R. J. Levinsky. 1989. Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome. Lancet ii:411-414.
7. Harris, E. S., T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 2000. The leukocyte integrins. J. Biol. Chem. 275:23409-23412.
8. Khaitan, A., D. M. Jandhyala, C. M. Thorpe, J. M. Ritchie, and A. W. Paton. 2007. The operon encoding SubAB, a novel cytotoxin, is present in Shiga toxin-producing Escherichia coli isolates from the United States. J. Clin. Microbiol. 45:1374-1375.
9. Lee, A. S. 2001. The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem. Sci. 26:504-510.
10. Lee, S. Y., M. S. Lee, R. P. Cherla, and V. L. Tesh. 2008. Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells. Cell. Microbiol. 10:770-780.
11. Matsuura, G., et al. 2009. Novel subtilase cytotoxin produced by Shigatoxigenic Escherichia coli induces apoptosis in Vero cells via mitochondrial membrane damage. Infect. Immun. 77:2919-2924.
12. May, K. L., J. C. Paton, and A. W. Paton. 2010. Escherichia coli subtilase cytotoxin induces apoptosis regulated by host Bcl-2 family proteins, Bax/Bak. Infect. Immun. 78:4691-4696.
13. Menge, C., L. H. Wieler, T. Schlapp, and G. Baljer. 1999. Shiga toxin 1 from Escherichia coli blocks activation and proliferation of bovine lymphocyte subpopulations in vitro. Infect. Immun. 67:2209-2217.
14. Nataro, J. P., and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
15. 5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP. Nature 443:548-552.
16. Paton, A. W., and J. C. Paton. 2005. Multiplex PCR for direct detection of Shiga toxigenic Escherichia coli strains producing the novel subtilase cytotoxin. J. Clin. Microbiol. 43:2944-2947.
17. 5 cytotoxins produced by Shiga toxigenic Escherichia coli. J. Exp. Med. 200:35-46.
18. Paton, A. W., M. C. Woodrow, R. M. Doyle, J. A. Lanser, and J. C. Paton. 1999. Molecular characterization of a Shiga toxigenic Escherichia coli O113: H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome. J. Clin. Microbiol. 37:3357-3361.
19. Paton, J. C., and A. W. Paton. 1998. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11:450-479.
20. Ramegowda, B., and V. L. Tesh. 1996. Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infect. Immun. 64:1173-1180.
21. Talbot, U. M., J. C. Paton, and A. W. Paton. 2005. Protective immunization of mice with an active-site mutant of subtilase cytotoxin of Shiga toxinproducing Escherichia coli. Infect. Immun. 73:4432-4436.
22. Tesh, V. L., B. Ramegowda, and J. E. Samuel. 1994. Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect. Immun. 62:5085-5094.
23. van Setten, P. A., L. A. Monnens, R. G. Verstraten, L. P. van den Heuvel, and V. W. van Hinsbergh. 1996. Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood 88:174-183.
24. 5 toxin that targets the endoplasmic reticulum. J. Infect. Dis. 196:1093-1101.
25. 5 toxin produced by Shiga toxigenic Escherichia coli. J. Infect. Dis. 202:1415-1423.
26. Wolfson, J. J., et al. 2008. Subtilase cytotoxin activates PERK, IRE1 and ATF6 endoplasmic reticulum stress-signalling pathways. Cell. Microbiol. 10: 1775-1786.
27. Yahiro, K., et al. 2006. Identification and characterization of receptors for vacuolating activity of subtilase cytotoxin. Mol. Microbiol. 62:480-490.